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Abstract
            The immunomodulatory properties of coconut protein were investigated in Swiss albino mice by immune
suppressed with cyclophosphamide (CP). CP is a commonly used anti-cancer drug which causes toxicity by its
reactive metabolites such as acrolein and phosphoramide mustard. In this study, the animals were grouped into four
of 6 mice per group. Assessment of immunomodulatory activity was carried out by testing the RBC, WBC, Platelet
and differential counts. Orally administered coconut protein in CP treated animals showed the increased levels of
RBC, WBC and Platelet counts. The results of treated groups were RBC (1.84 mm3), WBC (5720.84 mm3) and
platelet (3.79 mm3). The results showed Neutrophil (18.3%), Monocytes (9.58%), Eosinophil (7.54%), B-
lymphocytes (0.705%), T-lymphocytes (3.15%) and Hb (3.834g/dl) respectively.  The treated mice show an
increased number of cells revealing the immune stimulated condition. The results of this experiment showed that
coconut protein has strong immunomodulatory activity.
Key words: Cyclophosphamide, coconut protein, immunomodulatory, RBC (Red blood cells, WBC  (White blood
cells).
INTRODUCTION
The term immunomodulatory means regulation of the immune system by suppression and stimulation of the
cells and organs of the immune system (Bafuna and Mishra, 2005). Immunostimulation in a drug-induced
immunosuppression model and immunosuppression in an experimental hyper-reactivity model by the same
preparation can be said to be true immunomodulation (Patwardhan et al., 1990). Certain agents have been shown to
possess activity to normalize or modulate pathophysiological processes and are hence called immunomodulatory
agents (Wagner, 1984). A number of plant products are being investigated for immune response modifying activity
(Upadhyay, 1997). Cyclophosphamide acts on both cyclic and intermitotic cells, resulting in general depletion of
immune-competent cells. Cyclophosphamide (CP) is an alkylating agent widely used in anti-neoplastic therapy
(Baumann and Preiss, 2001; Fleming, 1997). It is effective against a variety of cancers such as lymphoma, myeloma
and chronic lymphocytic leukemia (Baumann and Preiss, 2001). CP-induced immunosuppression is reported to
prompt various types of infection (Angulo et al., 2002; Wijesundera, 1980; Williams and Luzio, 1979).
             Coconut palm (Cocos nucifera L.) is an economic plant which is cultivated in most tropical countries. A
coconut fruit is composed of about 38.5% shell, 51.7% kernel and 9.8% water (Dendy & Timmins, 1973).
Hypolipidemic effect of coconut protein is due to the high content of L-arginine (Mini et al., 2004), feeding coconut
kernel along with coconut oil in human volunteers has been found to reduce serum total and LDL cholesterol when
compared to feeding coconut oil alone (Padmakumaran Nair et al., 1998). In coconut, a large globulin was originally
described in 1930 and named cocosin (Sjogren et al., 1930). The coconut globulin cocosin (Osborne et al., 1916) is a
legume class reserve protein from coconut and belongs to the fourth group of proteins, having a molecular weight of
about 208 k Da. Components such as polysaccharides, lectins, proteins and peptides present in plants have been
shown to stimulate the immune system (Tzianabos, 2000; Bafna and Mishra, 2005). Use of plant as a source of
immunomodulators is still in infancy in modern medicine (Bafna and Mishra, 2005). The aim of the present study
was to investigate immunomodulatory activities of coconut protein in immune suppressed systems with
Cyclophosphamide.
 
 
MATERIALS AND METHODS
Separation of Coconut Protein
The nuts were freed from shells and skins and ground to a fine paste and suspended in 10% NaCl solution.
Toluene was added to remove fat. The mixture was stirred at room temperature for 24 h. The solution was freed from
oil and fat by filtering and centrifuging. Saturated ammonium sulfate was added to 60% saturation and the
precipitate was filtered and washed with 50% saturated ammonium sulfate solution. The resulting protein precipitate
was dissolved in 0.033 M sodium phosphate buffer, pH 6.7, containing 7% NaCl. The protein solution was then
dialyzed against the same buffer for 6 days (Balasundaresan et al., 2002).
Preparation of feed
            The animals were fed with a synthetic diet:
Coconut protein          -      120 g
Sago                           -      315 g
Groundnut oil            -      35 mL
Vitamins                   -      30 g
 
Sources of Laboratory Animals
In the present study, healthy adult male albino mice were used as experimental animals. The animals were
purchased from Perundhurai Medical College, Erode. Adult male mice of 12 weeks old, weighing about 100 – 150g
were selected.  They were housed in polypropylene cages.  Husk was renewed every 24 hours.  The animals were fed
with a standard diet (Sai Durga feeds and Foods, Bangalore, India) and water for normal animals. The mice were
maintained at the local animal house conditions.
Before starting the experiments the animals were acclimatized to the laboratory condition for 7 days. After
acclimatization of the laboratory condition, animals were pretreated with coconut protein for 30 days. CP (20
mg/kg/day) was given orally for 10 days for the animal of Group-II and III at the concentration of 20 mg/kg/day
from the 21st day for 10days.
Evaluation of the Immunomodulatory Activity of Coconut protein on Experimental Animals
 
 Twenty four Swiss albino mice were used to assess the effect of coconut protein on the immune system. The
mice were divided into 4 groups of six mice per cage. The first group was given normal diet and water and this
(Group-I) served as control. The second group served as test group (Group-II) fed with normal diet and induced
with the CP. The third group served as experimental animals (Group-III) and was given with coconut protein and
CP. The fourth group served as treated control (Group-IV) and was given only coconut protein containing coconut
protein, vitamins, fats and carbohydrates.
Haematological Test
At the end of the treatment, mice were sacrificed under chloroform anesthesia. The blood was collected
through cardiac puncture and blood was collected immediately. Haematological parameters were studied for White
Blood Cell (WBC), Red Blood Cell (RBC), platelet count, eosinophil, neutrophil and lymphocytes.
        The WBC count was done by Turke’s method, RBC by Hayem’s method, platelet by Rees and Ecker’s method
and haemoglobin by Sahli’s method. The differential counts were studied using Leishman’s stain and viewed under
the microscope. The results were shown in Table 1 & 2. 
Statistical Analysis
    The data were expressed as the mean ± standard deviation of the means (S.D) and statistical analysis was carried
out employing student’s t-test.
RESULTS AND DISCUSSION
Modification of immune functions by pharmacological agents is emerging as a major area of therapeutics.
The RBC, platelet count of Group III animals shows increased levels when compared with Group II animals. There
were slight differences between Group I and Group IV animals. The value of WBC dropped for the animals treated
with CP when compared with Group III. CP of 20 mg/kg is found to be the efficient potentiating dose of
hypersensitivity as compared with CP 200 mg/kg (Askenase et al., 1975). Animals treated with CP of 20 mg/ kg
showed maximum potentiation of hypersensitivity (because CP damaged short-lived suppressor T cells in immune
regulatory systems) (Askenase et al., 1975; Mitsuoka et al., 1976).
Table 1: The results of RBC, WBC, and Platelet count of normal and pretreated groups.
Parameters Group-I Group-II Group-III Group-IV
RBC cells count/
mm3
1.29±0.075 1.49±0.15 1.84±0.28 1.54±0.043
WBC cells
count/mm3
4562±62.07 4670.94±162.4 5720.84±53.5 5518.2±303
Platelet Lakhs/
mm3
3.16±0.34 2.70±0.03 3.79±0.056 3.37±0.96
 
Bone marrow is a site of continued proliferation and turnover of blood cells, and is a source of cells involved
in immune reactivity (Pelczar et al., 1990). A high degree of cell proliferation renders bone marrow a sensitive
target, particularly to cytotoxic drugs. In fact, bone marrow is the organ most affected during any
immunosuppression therapy with this class of drug. Loss of stem cells and inability of bone marrow to regenerate
new blood cells will result in thrombocytopenia and leucopenia. The results indicate modulation of bone marrow
activity, namely suppression when used CP alone and stimulation to counteract with CP-induced pretreated coconut
protein groups.
 
Table 2: The results of differential counts of normal and pretreated groups.
Parameters Group-I Group-II Group-III Group-IV
Neutrophil (%)
Monocytes (%)
Eosinophil (%)
B- lymphocytes
(%)
T-lymphocytes
(%)
Hb  g / dl
13.62 ± 0.24
6.32 ± 0.34
6.54 ± 0.27
0.425 ± 0.78
 
2.425 ± 0.81
 
1.70 ± 0.05
 
11.28 ± 0.29
5.5 ± 0.29
5.59 ± 0.29
0.211 ± 0.014
 
1.886 ± 0.033
 
2.78±  0.11
18.3 ± 0.21
9.58 ± 0.21
7.54 ± 0.24
0.705 ± 0.0005
 
3.15 ± 0.014
 
3.834 ± 0.07
12.58 ± 0.23
7.38 ± 0.37
6.58 ± 0.27
0.32 ± 0.008
 
0.74 ± 0.008
 
3.58 ± 0.03
 
 T-lymphocyte and other key cells of the immune system are known to activate production of antibody
polymorphonuclear granulocyte to destroy the antigen (Prescott, 1999). The number of neutrophil count increases
significantly during treatment of protein. T and B-lymphocytes of Group III animals increased when compared with
Group I. Dose of CP 20 mg/kg, reported as a B-cell depleting dose (Askenase et al., 1975). An increased level in
lymphocyte has been found in experimental groups. Hemoglobin also increases in Group III and Group IV when
compared with group II animals. Immunosuppression involves an act that reduces the activation or efficacy of the
immune system. Bone marrow is the flexible tissue found in the hollow interior of bones. In adults, marrow in large
bones produces new blood cells. When it is in suppressed condition WBC count level gets reduced.
            Coconut protein has the ability to stimulate the immune system by activating the bone marrow cells. By
activating the cells, the treated animal parameters showed similar normal condition. The increased levels of the
immune cells showed a positive result. The result obtained in the present study has showed the immunomodulatory
activity of coconut protein in vivo.
CONCLUSION
 Cyclophosphamide is a potent suppressor of immune function, at high doses resulting in a sustained decrease
in both the number and function of T and B cells (Cupps et al., 1982).  It is an effective therapy in certain
autoimmune diseases. Plant based immune stimulation may also contribute to the therapy of the autoimmune
diseases. Coconut protein has counteractivity to cyclophosphamide-induced myelosuppression and
thrombocytopenia. Thus, Coconut protein has immunostimulatory activity with regard to IgE mediated and cell-
mediated hyper-reactivity. Further studies are required to examine the exact mechanism of CP function.
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